%0 Case Reports
%T Crizotinib-associated renal cyst development may be associated with prolonged progression-free survival in patients with ALK-positive non-small-cell lung cancer: Case report and review of the literature.
%A Wiest NE
%A Tzou KS
%A Olson MT
%A Herchko SM
%A Bajalia EM
%A Thiel DD
%A Lou Y
%A Zhao Y
%A Manochakian R
%J Clin Case Rep
%V 9
%N 6
%D Jun 2021
%M 34136235
暂无%R 10.1002/ccr3.4278
%X Non-small cell lung cancer patients with anaplastic lymphoma kinase or c-ros oncogene 1 mutations who are treated with the tyrosine kinase inhibitor crizotinib rarely develop crizotinib-associated renal cysts (CARCs). Here, we present a case report and review of the literature supporting the hypothesis that CARCs may correlate positively with progression-free survival.